Literature DB >> 35146193

Choroidal effusion as a manifestation of central serous chorioretinopathy: A case report.

Tuan Tran1,2,3, Mali Okada2,3, Jonathon Goh2,3, ThomasJ Gin2,3, C Alex Harper2,3.   

Abstract

PURPOSE: To report a case of bullous central serous chorioretinopathy presenting with large choroidal effusions. OBSERVATIONS: A patient presented with typical features of bullous central serous chorioretinopathy with large choroidal effusions. He had a previous history of bullous central serous chorioretinopathy in his other eye. The condition worsened after a short course of oral prednisolone, consistent with central serous chorioretinopathy. Surgical management with sclerectomies resulted in resolution of serous retinal detachment, choroidal effusions and subfoveal fluid.
CONCLUSIONS: We report choroidal effusions as a potential manifestation of central serous chorioretinopathy which may aid in our understanding in the pathogenic mechanisms of this condition. Furthermore, we demonstrate that surgical sclerectomies as a potential treatment option for serous retinal detachment and choroidal effusions in this condition.
© 2022 The Authors.

Entities:  

Keywords:  BCVA, Best corrected visual acuity; CSC, Central serous chorioretinopathy; Central serous chorioretinopathy; Choroidal effusion; FAF, Fundus Autofluorescence; FFA, Fundus fluoresceine angiogram; OCT, Optical coherence tomography; Pachychoroid; UES, Uveal effusion syndrome

Year:  2022        PMID: 35146193      PMCID: PMC8802005          DOI: 10.1016/j.ajoc.2022.101311

Source DB:  PubMed          Journal:  Am J Ophthalmol Case Rep        ISSN: 2451-9936


  18 in total

1.  The indocyanine green findings in idiopathic uveal effusion syndrome.

Authors:  Atul Kumar; Sachin Kedar; Rajinder P Singh
Journal:  Indian J Ophthalmol       Date:  2002-09       Impact factor: 1.848

2.  Wide-angle indocyanine green angiography.

Authors:  R F Spaide; D A Orlock; B Herrmann-Delemazure; A P Ciardella; L A Yannuzzi; K B Freund; Y L Fisher; D R Guyer; J S Slakter; J A Sorenson
Journal:  Retina       Date:  1998       Impact factor: 4.256

3.  Loculation of Fluid in the Posterior Choroid in Eyes With Central Serous Chorioretinopathy.

Authors:  Richard F Spaide; Edwin H Ryan
Journal:  Am J Ophthalmol       Date:  2015-08-20       Impact factor: 5.258

4.  Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1973-05       Impact factor: 5.258

5.  Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging.

Authors:  Chandrakumar Balaratnasingam; K Bailey Freund; Anna M Tan; Sarah Mrejen; Alex P Hunyor; David J Keegan; Kunal K Dansingani; Pouya N Dayani; Irene A Barbazetto; David Sarraf; Lee M Jampol; Lawrence A Yannuzzi
Journal:  Ophthalmology       Date:  2016-04-12       Impact factor: 12.079

6.  Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy.

Authors:  Claudine E Pang; Vinnie P Shah; David Sarraf; K Bailey Freund
Journal:  Am J Ophthalmol       Date:  2014-05-01       Impact factor: 5.258

7.  Pathogenesis of disciform detachment of the neuroepithelium.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1967-03       Impact factor: 5.258

Review 8.  Uveal effusion syndrome.

Authors:  Mohammed Elagouz; Dinu Stanescu-Segall; Timothy L Jackson
Journal:  Surv Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 6.048

9.  Digital indocyanine green videoangiography of central serous chorioretinopathy.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; A Ho; D Orlock
Journal:  Arch Ophthalmol       Date:  1994-08

10.  Type III uveal effusion syndrome suspected to be related to pachychoroid spectrum disease: A case report.

Authors:  Yuya Terubayashi; Seita Morishita; Ryohsuke Kohmoto; Masashi Mimura; Masanori Fukumoto; Takaki Sato; Takatoshi Kobayashi; Teruyo Kida; Tsunehiko Ikeda
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.